Approvals/TGA/SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 25 mg tablet blister pack

Approved

STANDARD

SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 25 mg tablet blister pack

Maple Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e6aca530355c00e5
Product Name: SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 25 mg tablet blister pack
Artg Id: 384800
Artg Name: SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 25 mg tablet blister pack
Sponsor: Maple Healthcare Pty Ltd
Company Detail Path: /organization/maple-healthcare-pty-ltd
Artg Date: 2023-04-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/acfaadd47a2010f4591f4b3283a378f6.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/5aad98331780e282db394d031cdfccbe.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

e6aca530355c00e5

Type

Standard